New America High Income Fund About To Put More Money In Your Pocket (HYB)

Looking at the universe of stocks we cover at Dividend Channel, on 6/12/15, New America High Income Fund (HYB) will trade ex-dividend, for its monthly dividend of $0.065, payable on 6/30/15. As a percentage of HYB's recent stock price of $9.00, this dividend works out to approximately 0.72%, so look for shares of New America High Income Fund to trade 0.72% lower — all else being equal — when HYB shares open for trading on 6/12/15.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for HYB, showing historical dividends prior to the most recent $0.065 declared by New America High Income Fund:

HYB+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from HYB is likely to continue, and whether the current estimated yield of 8.67% on annualized basis is a reasonable expectation of annual yield going forward. The chart below shows the one year performance of HYB shares, versus its 200 day moving average:

New America High Income Fund 200 Day Moving Average Chart

Looking at the chart above, HYB's low point in its 52 week range is $8.58 per share, with $10.05 as the 52 week high point — that compares with a last trade of $9.00.

In Wednesday trading, New America High Income Fund shares are currently up about 0.3% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says